Hudson Institute of Medical Research is an independent, not-for-profit medical research institute, based in the Melbourne suburb of Clayton in Victoria. The Institute hosts approximately 450 researchers, postgraduate students and support staff. Research at Hudson Institute works to understand, prevent and treat women’s and baby health, cancer, innate immunity and infectious diseases, and reproductive health. The current director and CEO is distinguished researcher and international authority on microbiology and immunology, . The Institute is partnered with Monash University and Monash Health, and is co-located with both organisations at the in Clayton.
Purpose
The Institute’s purpose is stated as ‘unravelling the mysteries of nature to cure disease’.
Organisation
Hudson Institute of Medical Research is organised into five specialist research centres :
Within these centres, 48 research groups undertake basic, translational and clinical research into a range of diseases.
Research
Hudson Institute scientists examine
The body’s innate immune responses and their role in cancer, autoimmune diseases and inflammation; infectious diseases including HIV, herpes and influenza.
The molecular, genetic, endocrine and mitochondrial processes underlying cancer tumour development to identify and develop more effective cancer diagnostics and treatments.
Health areas and diseases include
History
Hudson Institute of Medical Research was formed in January 2014 through a merger of the Monash Institute of Medical Research and Prince Henry's Institute of Medical Research. Hudson Institute of Medical Research was named in honour of the late Professor Bryan Hudson, the founding Professor of Medicine at Monash University and first director of the Prince Henry’s Hospital Medical Research Centre, which later became Prince Henry’s Institute of Medical Research. Professor Hudson was one of Australia’s leading endocrinologists, and a renowned physician-scientist responsible for early work on the male reproductive hormone, Inhibin.
Education
The Institute has a large student population, predominantly enrolled through Monash University, and hosted 168 postgraduate students in 2015.
Facilities
A new federally-funded $87.5 million Monash Health Translation Precinct Translational Research Facility was officially opened by the Australian Health Minister Sussan Ley MP in March 2016. The facility contains research laboratory space, a platform technologies floor and a dedicated clinical trials centre, with eight beds and 21 chairs for the purpose of translating research into patient treatments. The Institute’s scientists and students have access to the MHTP Technology Platforms, which contain the following capabilities:
